Cutting Edge Therapeutics, Inc (CET) is a start-up biopharmaceutical company focused on licensing and developing a portfolio of exciting and innovative therapeutics for CNS disorders, Cancer and Infectious Diseases. We are dedicated to finding cutting edge treatments to address unmet medical needs worldwide. We are committed to building a portfolio of new therapies to meet the growing cases. CET is hoping to be the first to market novel therapeutics in the emerging field of oncology, neurology and immunotheraphy.
View Top Employees from Cutting Edge TherapeuticsWebsite | http://www.cetrx.com |
Revenue | $2.2 million |
Employees | 1 (1 on RocketReach) |
Founded | 2010 |
Address | 45 Dan Rd, Canton, Massachusetts 02021, US |
Phone | (617) 910-9678 |
Fax | (617) 910-9679 |
Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Retail |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Cutting Edge Therapeutics employee's phone or email?
The Cutting Edge Therapeutics annual revenue was $2.2 million in 2023.
Lisa Davidson is the Owner of Cutting Edge Therapeutics.
1 people are employed at Cutting Edge Therapeutics.
Cutting Edge Therapeutics is based in Canton, Massachusetts.
The NAICS codes for Cutting Edge Therapeutics are [32, 3254, 325].
The SIC codes for Cutting Edge Therapeutics are [28, 283].